Navigation Links
Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc.
Date:7/24/2008

BEDFORD, Mass., July 24 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced the successful completion of the tender offer by its direct wholly-owned subsidiary, Thunder Tech Corp., for all outstanding shares of Third Wave Technologies, Inc. (Nasdaq: TWTI) at a price of $11.25 per share in cash.

The subsequent offering period expired at 12:00 midnight, New York City time, on Wednesday, July 23, 2008. The initial tender offer period expired at 12:00 midnight, New York City time, on Wednesday, July 16, 2008.

The depositary for the tender offer advised Hologic and the Purchaser that, as of the expiration of the subsequent offering period, approximately 47,968,050 shares were validly tendered and not withdrawn in the tender offer, representing approximately 95.8% of Third Wave's issued and outstanding shares. All validly tendered shares were accepted for payment in accordance with the terms of the tender offer.

Hologic is in the process of completing the acquisition of Third Wave though a short form merger in which Third Wave will become a wholly owned subsidiary of Hologic. In the short form merger, which will be completed as soon as practicable, all outstanding shares of Third Wave not purchased in the tender offer, and not held by a holder who demands appraisal rights for such shares under the Delaware General Corporation Law, will be converted into the right to receive $11.25 per share in cash. Following the merger, detailed instructions will be mailed to Third Wave stockholders
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Hologic, Inc. to Release First Quarter Fiscal 2008 Operating Results Thursday, January 31st Before Market Opens
2. Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Hologic Announces First Quarter Fiscal 2008 Operating Results
4. Hologic to Present at the Sun Trust Robinson Humphreys 37th Annual Institutional Conference
5. Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens
6. Hologic to Present at the Bank of America Healthcare Conference
7. Hologic to Present at the Citigroup Investment Research Global Healthcare Conference
8. Hologic to Present at the Needham Seventh Annual Biotechnology and Medical Technology Conference
9. Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period
10. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
11. AEterna Zentaris completes management team with the appointment of Chief Medical Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(PD...ishedNovember27,2009astheex-dividenddateforits$200...hesecuritizationtransactioncompletedonNovember2,20...kholdersofrecordontherecorddate,December1,2009.NAS...at$1.67pershareofcommonstockforpurposesoftheex-div...
(Date:11/23/2009)...ntec’s Sporicidin disinfectant solution and ...sinfectants against H1N1 and Influenza A., , ...er 24, 2009 -- Contec Inc, the leading manufacture...ir Sporicidin disinfectants have been deemed by ...es, including Pandemic 2009 H1N1 influenza A virus...
(Date:11/23/2009)...Nov.23/PRNewswire/--Frost&Sullivan,theGrowthPa...nstratingleadershipandinnovationThursday,November1...anquetheldinSanAntonio,Texas. ,, (Logo: http://..., TheHealthcareInnovationAwardsaregiventocompanie...andmanagementofhealthcare.Suchcompanieshaveshownsu...
(Date:11/20/2009)... , , , , , , , ... , A team of scientists from Washington Univers...Spring Harbor Laboratory and Iowa State University..., , Click here for more informatio... , , , , , , , ...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...,subsidiary of MGT Capital Investments, Inc. (Amex...t of Computer-Aided Detection (CAD) and image,anal... and diagnosis of,disease, announces a new global ...ing medical imaging and picture archiving and comm...ITT-Medicsight products for the,detection of color...
... with the Disease Receive,Pharmacotherapy Within a...t From Decision Resources, ..., one,of the world,s leading research and advisory...inds that Boehringer Ingelheim,s Flomax, also mark...an,s drug of choice for newly,diagnosed benign pro...
...st Partners,announced today the appointment of thr...ure capital firm,s Advisory Committee: Caltech,pre... Dr. Leroy Hood, and,former FDA commissioner Dr. M...ter of experienced professional advisors, providin... companies., "Drs. Chameau, Hood and McClellan ea...
Other Biology Technology:Medicsight Announces New Marketing Partnership with INFINITT 2Medicsight Announces New Marketing Partnership with INFINITT 3More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Line Therapy 2More Than Half of Patients Treated for Benign Prostatic Hyperplasia Receive Boehringer Ingelheim's Flomax as First-Line Therapy 3Prestigious Scientific Leaders Join InterWest Advisory Committee 2Prestigious Scientific Leaders Join InterWest Advisory Committee 3Prestigious Scientific Leaders Join InterWest Advisory Committee 4
(Date:11/23/2009)...160 participants gathered this week for the sevent...E conference. This year,s topic, "Synthetic Biolog...dical researchers to explore the engineering, scie... field of synthetic biology. , Bonnie L. Bassler...ersity and this year,s conference chair, challenge...
(Date:11/23/2009)...cing some of the highest resolution images of pept...e a deeper understanding how biomolecules manipula...a new treatment for kidney stones using biomolecul... online edition of the journal Proceedings of the...des interact with mineral surfaces by accelerating...
(Date:11/23/2009)...dies reveal in unprecedented detail how the riboso...proteins and guide them toward their destination i...amics flexible fitting (MDFF) to examine the inter...r partners. , The first study, in Proceedings ... intimate signaling between the ribosome and an el...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 1New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 2New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 3New e p t 28R 29 BabyCenter 28R 29 Fertility Report Reveals 70 Percent of Moms Want Tighter Regulation on In Vitro Fertilization 52112 4Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange 28NYCLIX 29 to Share Meaningful Data and Enhance Patient Care 52108 1Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange 28NYCLIX 29 to Share Meaningful Data and Enhance Patient Care 52108 2Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange 28NYCLIX 29 to Share Meaningful Data and Enhance Patient Care 52108 3Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange 28NYCLIX 29 to Share Meaningful Data and Enhance Patient Care 52108 4NxStage to Report Second Quarter 2009 Financial Results 52105 1NxStage to Report Second Quarter 2009 Financial Results 52105 2
...f Technology for the first time have shown the ear...t leads to the formation of bones, teeth and sea s...ron microscope to capture a three-dimensional imag...s process. The results provide a greater understan...This creates a prospect of better materials and pr...
... . , Montreal, May 14th 2009 - The Canadian pol...as already proved to be effective in preventing ne... the British Medical Journal by a group of resea...eart Disease (MAUDE Unit), the Research Institute ...McGill University, shows that folic acid also decr...
...lies crucial to switch a stem cell,s fate, is not ...versity of Oregon biochemists. They,ve found that ...ic cop that directs which roads daughter cells wil... or membrane, Miranda isn,t," says Kenneth E. Preh...ember of the UO,s Institute of Molecular Biology. ...
Other Biology News:Focus on the formation of bones, teeth and shells 2Folic acid to prevent congenital heart defects 2How an enzyme tells stem cells which way to divide 2
HeavyPeptide AQUA Custom4 Kit from Thermo Scientific
Mouse Anti-Rat L-Pyruvate Kinase Monoclonal Antibody, Unconjugated, Clone AD12 from ScheBo Biotech AG
Extensor Control & Template from ABgene
Lambda Control Kit from ABgene
Biology Products: